How Trenbolone Affects Prolactin

Trenbolone and its metabolites bind progesterone receptors in pituitary lactotroph cells with significant affinity. Progesterone receptor activation in lactotrophs stimulates prolactin synthesis and secretion. This is independent of the dopaminergic pathway that normally regulates basal prolactin levels, which is why standard dopamine-mediated prolactin control may be overwhelmed during trenbolone use. Elevated prolactin in turn suppresses GnRH pulsatility and LH secretion at the hypothalamic-pituitary level, adding another layer of HPG axis suppression beyond trenbolone's direct androgenic effects.

Prolactin may rise to 20-40 ng/mL or higher during trenbolone use (normal male range: 2-18 ng/mL). The elevation is dose-dependent and may persist for 2-4 weeks after the last trenbolone acetate injection (half-life approximately 3 days). Higher doses and longer cycles produce more pronounced prolactin elevation. Some individuals are more susceptible to progestin-driven prolactin elevation than others.

Check prolactin at baseline before starting trenbolone, at mid-cycle (4-6 weeks in), and at the start of PCT. If prolactin remains above 20 ng/mL at the mid-PCT blood draw (after trenbolone has cleared), this may be impairing LH recovery and requires intervention. Recheck prolactin at the post-PCT confirmation draw.

Cabergoline 0.25-0.5 mg twice weekly is the standard treatment for trenbolone-induced hyperprolactinemia. Start cabergoline if prolactin exceeds 20 ng/mL with symptoms (sexual dysfunction, gynecomastia, low mood) or if it remains elevated during PCT and may be impairing recovery. Avoid overtreatment: prolactin below 2 ng/mL from excessive cabergoline can cause impulse control issues. Taper cabergoline once prolactin normalizes. If prolactin remains elevated 6-8 weeks after the last trenbolone dose and cabergoline fails to normalize it, investigate for prolactinoma (rare but important to exclude).